Brainsway (BRSYF) EBIT Growth (3y) (2021 - 2026)
Powered by 
Analysis
Brainsway (BRSYF) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 13.06% |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 55.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.78% |
| Mar 31, 2026 | 36.56% |
| Dec 31, 2025 | 34.69% |
| Sep 30, 2025 | 31.18% |
| Jun 30, 2025 | 31.77% |
| Mar 31, 2025 | 33.68% |
| Dec 31, 2024 | 31.94% |
| Sep 30, 2024 | 30.61% |
| Jun 30, 2024 | 33.65% |
| Mar 31, 2024 | 28.38% |
| Dec 31, 2023 | 34.85% |
| Sep 30, 2023 | 39.00% |
| Jun 30, 2023 | -84.17% |
| Mar 31, 2023 | -0.42% |
| Dec 31, 2022 | -60.97% |
| Sep 30, 2022 | -61.84% |
| Jun 30, 2022 | -39.99% |
| Mar 31, 2022 | -42.95% |
| Dec 31, 2021 | -41.43% |
| Sep 30, 2021 | -49.04% |